Free Trial

CytoDyn Inc. (OTCMKTS:CYDY) Sees Significant Growth in Short Interest

CytoDyn logo with Medical background

CytoDyn Inc. (OTCMKTS:CYDY - Get Free Report) saw a large growth in short interest in the month of December. As of December 31st, there was short interest totalling 20,123,400 shares, a growth of 15.0% from the December 15th total of 17,499,100 shares. Based on an average daily trading volume, of 6,176,200 shares, the short-interest ratio is currently 3.3 days.

CytoDyn Stock Up 1.3 %

CYDY traded up $0.00 during trading on Friday, hitting $0.15. The company had a trading volume of 1,217,001 shares, compared to its average volume of 2,325,929. The company has a market capitalization of $185.14 million, a PE ratio of -7.54 and a beta of -0.10. CytoDyn has a one year low of $0.10 and a one year high of $0.32. The firm's 50-day moving average price is $0.12 and its 200 day moving average price is $0.14.

About CytoDyn

(Get Free Report)

CytoDyn Inc, a clinical-stage biotechnology company, engages in the development of treatments for multiple therapeutic indications. The company is involved in the clinical development of leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19, human immunodeficiency virus (HIV), Metabolic dysfunction-associated steatohepatitis (MASH), and solid tumors in oncology, such as metastatic triple-negative breast cancer.

Read More

Should You Invest $1,000 in CytoDyn Right Now?

Before you consider CytoDyn, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CytoDyn wasn't on the list.

While CytoDyn currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

7 Large-Cap Stocks Headed for Strong, Steady Gains in 2025

7 Large-Cap Stocks Headed for Strong, Steady Gains in 2025

While 2025 may not deliver massive returns, so MarketBeat analyst Chris Markoch shares his list of seven stocks primed for consistent performance.

Related Videos

The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Small Caps, Financials & Bitcoin Lead the Rising Bull Market: Chris Rowe’s Top Picks
Massive Market Moves Following Trump Win: Tesla, JP Morgan, & Bitcoin Soar

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines